CY1110665T1 - Αναστολεις hiv ιντεγκρασης - Google Patents

Αναστολεις hiv ιντεγκρασης

Info

Publication number
CY1110665T1
CY1110665T1 CY20101100533T CY101100533T CY1110665T1 CY 1110665 T1 CY1110665 T1 CY 1110665T1 CY 20101100533 T CY20101100533 T CY 20101100533T CY 101100533 T CY101100533 T CY 101100533T CY 1110665 T1 CY1110665 T1 CY 1110665T1
Authority
CY
Cyprus
Prior art keywords
hiv
inhibitions
integration
treatment
hiv integration
Prior art date
Application number
CY20101100533T
Other languages
English (en)
Inventor
B Narasimhulu Naidu
Yasutsugu Ueda
John D Matiskella
Michael A Walker
Jacques Banville
Francis Beaulieu
Carl Ouellet
Serge Plamondon
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of CY1110665T1 publication Critical patent/CY1110665T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Η εφεύρεση περιλαμβάνει σειρά δικυκλικών ενώσεων πυριμιδινόνης του τύπου I οι οποίες αναστέλλουν την HIV ιντεγκράση και εμποδίζουν την ιική ενωσμάτωση σε ανθρώπινο DNA. Η δράση αυτή καθιστά τις ενώσεις χρήσιμες για την αγωγή της HIV μόλυνσης και του AIDS. Η εφεύρεση επίσης περιλαμβάνει φαρμακευτικές συνθέσεις και μεθόδους για την αγωγή ατόμων μολυσμένων με HIV. [I].
CY20101100533T 2005-11-17 2010-06-11 Αναστολεις hiv ιντεγκρασης CY1110665T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73778105P 2005-11-17 2005-11-17
US11/590,637 US8039458B2 (en) 2005-11-17 2006-10-31 HIV integrase inhibitors
EP06837651A EP1948666B1 (en) 2005-11-17 2006-11-15 Hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
CY1110665T1 true CY1110665T1 (el) 2015-06-10

Family

ID=38041727

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100533T CY1110665T1 (el) 2005-11-17 2010-06-11 Αναστολεις hiv ιντεγκρασης

Country Status (20)

Country Link
US (1) US8039458B2 (el)
EP (1) EP1948666B1 (el)
JP (1) JP2009515981A (el)
KR (1) KR20080069254A (el)
CN (1) CN101360752B (el)
AR (1) AR057896A1 (el)
AT (1) ATE461202T1 (el)
AU (1) AU2006316582B2 (el)
CY (1) CY1110665T1 (el)
DE (1) DE602006013025D1 (el)
DK (1) DK1948666T3 (el)
ES (1) ES2341132T3 (el)
HR (1) HRP20100247T1 (el)
NO (1) NO20081935L (el)
PE (1) PE20071080A1 (el)
PL (1) PL1948666T3 (el)
PT (1) PT1948666E (el)
SI (1) SI1948666T1 (el)
TW (1) TW200738728A (el)
WO (1) WO2007061714A1 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763630B2 (en) * 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
CA2714033A1 (en) * 2008-02-07 2009-08-13 Bayer Cropscience Ag Insecticidal arylpyrrolines
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
WO2010042391A2 (en) * 2008-10-06 2010-04-15 Merck Sharp & Dohme Corp. Hiv integrase inhibitors
US8143244B2 (en) 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
JP2012527414A (ja) 2009-05-19 2012-11-08 バイエル・クロップサイエンス・アーゲー 殺虫性アリールピロリン
CN102574854B (zh) * 2009-10-13 2014-04-16 伊兰科动物健康爱尔兰有限公司 大环整合酶抑制剂
US8383639B2 (en) * 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
US8822471B2 (en) 2011-03-14 2014-09-02 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
WO2012168315A1 (en) 2011-06-09 2012-12-13 Boehringer Ingelheim International Gmbh Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
CN104185420B (zh) 2011-11-30 2017-06-09 埃默里大学 用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂
EP2880027B1 (en) 2012-08-02 2016-09-28 Boehringer Ingelheim International GmbH N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
EP2931730B1 (en) 2012-12-17 2019-08-07 Merck Sharp & Dohme Corp. 4-pyridinonetriazine derivatives as hiv integrase inhibitors
WO2014172188A2 (en) 2013-04-16 2014-10-23 Merck Sharp & Dohme Corp. 4-pyridone derivative compounds and uses thereof as hiv integrase inhibitors
CA2909938A1 (en) * 2013-04-22 2014-10-30 Abbvie Inc. Thiazoles and uses thereof
WO2014183532A1 (en) 2013-05-17 2014-11-20 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
WO2014200880A1 (en) 2013-06-13 2014-12-18 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
PE20160501A1 (es) 2013-09-27 2016-05-14 Merck Sharp & Dohme Derivados de quinolizina sustituidos utiles como inhibidores de integrasa del vih
KR102542097B1 (ko) * 2015-01-16 2023-06-09 바이엘 크롭사이언스 악티엔게젤샤프트 4-시아노피페리딘 하이드로클로라이드의 제조 방법
WO2016187788A1 (en) 2015-05-25 2016-12-01 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds useful for treating hiv infection
WO2017087257A1 (en) 2015-11-17 2017-05-26 Merck Sharp & Dohme Corp. Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors
US10544155B2 (en) 2015-12-15 2020-01-28 Merck Sharp & Dohme Corp. Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
WO2017113288A1 (en) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
WO2018010163A1 (zh) * 2016-07-15 2018-01-18 泸州东方农化有限公司 一种1,2,4-三唑-3-硫酮化合物的合成方法及其中间体
CN110062627A (zh) 2016-12-02 2019-07-26 默沙东公司 可用作hiv整合酶抑制剂的三环杂环化合物
JOP20190130A1 (ar) 2016-12-02 2019-06-02 Merck Sharp & Dohme مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
EP3573984A4 (en) 2017-01-26 2020-07-29 Merck Sharp & Dohme Corp. USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS
CN113795491A (zh) * 2019-04-30 2021-12-14 上海拓界生物医药科技有限公司 桥环-3,4-二氢-吡啶并[1,2-a]吡嗪-1,8-二酮化合物及其药物用途
CN114426540B (zh) * 2020-10-29 2024-04-26 上海拓界生物医药科技有限公司 吡啶并[1,2-a]吡嗪-1,8-二酮类前药衍生物、其制备方法及其应用
CN113372335B (zh) * 2021-07-05 2023-02-24 山东大学 一种含有1,2,4-三唑硫醚的苯丙氨酸衍生物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0317749A (pt) * 2002-12-27 2005-11-22 Angeletti P Ist Richerche Bio Composto, composição farmacêutica, e, uso de um composto
AR046938A1 (es) 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
TW200526635A (en) 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
US7981879B2 (en) * 2005-03-31 2011-07-19 Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. HIV integrase inhibitors
US7741315B2 (en) 2005-05-10 2010-06-22 Merck Sharp & Dohme Corp. HIV integrase inhibitors

Also Published As

Publication number Publication date
DE602006013025D1 (de) 2010-04-29
AR057896A1 (es) 2007-12-26
SI1948666T1 (sl) 2010-06-30
US20070111984A1 (en) 2007-05-17
KR20080069254A (ko) 2008-07-25
NO20081935L (no) 2008-06-24
ATE461202T1 (de) 2010-04-15
HRP20100247T1 (hr) 2010-06-30
PE20071080A1 (es) 2007-11-19
PL1948666T3 (pl) 2010-08-31
AU2006316582B2 (en) 2012-01-19
TW200738728A (en) 2007-10-16
DK1948666T3 (da) 2010-05-25
EP1948666B1 (en) 2010-03-17
US8039458B2 (en) 2011-10-18
CN101360752B (zh) 2012-09-05
ES2341132T3 (es) 2010-06-15
CN101360752A (zh) 2009-02-04
PT1948666E (pt) 2010-05-17
JP2009515981A (ja) 2009-04-16
WO2007061714A1 (en) 2007-05-31
EP1948666A1 (en) 2008-07-30
AU2006316582A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
CY1110665T1 (el) Αναστολεις hiv ιντεγκρασης
CY1110266T1 (el) Δικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις της hiv ιντεγκρασης
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
NO20082135L (no) HIV integrase inhibitorer
NO20065443L (no) HIV-Integraseinhibitorer: Sykliske pyrimidinonforbindelser
CY1115580T1 (el) Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξικης πιπεραζινης
WO2007059125A3 (en) Hiv integrase inhibitors
WO2008002959A3 (en) Hiv integrase inhibitors
CY1122841T1 (el) Πολυαλκυλενικες πολυμερικες ενωσεις και χρησεις αυτων
EA201200631A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
NO20080797L (no) Bicykliske heterocykler som HIV Integrase inhibitorer
EA200802203A1 (ru) Дикетопиперазиновые и пиперидиновые производные в качестве противовирусных агентов
CY1118279T1 (el) Φαρμακευτικeς συνθeσεις
CY1106207T1 (el) Αντιιικα παραγωγα νουκλεοζιτων
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
CY1113103T1 (el) Φωσφονικα νουκλεοσιδιων και αναλογα εξ αυτων για την αγωγη των λοιμωξεων-hpv
NO20083585L (no) Hetero-bisykliske antivirale forbindelser
BRPI0508876A (pt) pró medicamentos de agentes antivirais de piperazina e piperidina substituìda
DE60323133D1 (de) Cyclohexylverbindungen als ccr5-antagonisten
DK1765337T3 (da) Kombination af tenofovir, ritonavir og TMC114
WO2008118849A3 (en) Hiv-1 protease inhibitors
EA201101397A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
UY29189A1 (es) Nonadepsipeptidos acilados ii
CY1109187T1 (el) Νεα μακρολιδια
SE0302304D0 (sv) Novel compounds